LPL Financial
CGON icon

LPL Financial’s CG Oncology CGON Stock Holding History

LPL Financial’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$439K Buy
6,483
+282
+5% +$16K ﹤0.01% 4886
2025
Q4 		$257K Buy
6,201
+551
+10% +$22.8K ﹤0.01% 5264
2025
Q3 		$228K Buy
+5,650
New +$164K ﹤0.01% 5266

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LPL Financial's CGON Position: Q1 2026 in Review

LPL Financial increased its CG Oncology (CGON) stake by 4.5% in Q1 2026, buying an estimated $16K and bringing the position to 6,483 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #4886.

LPL Financial first reported a position in CGON in Q3 2025 and has held it in 3 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • LPL Financial held 6,483 shares of CG Oncology worth $439K as of Q1 2026.
  • LPL Financial bought 282 CG Oncology shares in Q1 2026, an estimated $16K.
  • CG Oncology made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #4886 holding.
  • LPL Financial first reported a position in CG Oncology in Q3 2025 and has held it in 3 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.